BOONE CAPITAL MANAGEMENT LLC
Filing Date
Global Rank
#2,983
/ 8,232
▲ 411
Top Industry
Biotechnology
42.4%
3Y Alpha vs SPY
-18.9%
Period ended 2 months ago
Filed May 15, 2026 · 29d
14 quarters · since Dec 2022
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+6.1%
SPY
+76.5%
Annualised alpha
-18.9%
Max drawdown
−24.6%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
13 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
11.9%
−2.7 pts
Top 5
55.5%
−0.7 pts
Top 10
90.6%
+1.5 pts
HHI
912
Diversified−6
Portfolio Trend
14 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $326,408,246 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
5 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| BMRN | Biomarin Pharmaceutical Inc | +135,991 | 547,871 | $30,949,232 | |
| IONS | Ionis Pharmaceuticals Inc | +82,689 | 500,522 | $37,584,196 | |
| BBIO | BridgeBio Pharma, Inc. | +43,866 | 228,829 | $16,992,841 | |
| CI | Cigna Group | +41,069 | 137,522 | $36,683,993 | |
| UNH | Unitedhealth Group Inc | +17,464 | 79,226 | $21,437,763 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
5 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| TFX | Teleflex Inc | 278,792 | $33,346,311 | |
| GRDN | Guardian Pharmacy Services, Inc. | 631,193 | $23,770,728 | |
| AZN | Astrazeneca PLC | 110,101 | $21,714,119 | |
| AVNS | Avanos Medical, Inc. | 1,184,909 | $16,600,575 | |
| TENX | Tenax Therapeutics, Inc. | 200,000 | $3,198,000 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
5 positions
13 positions ·
$326,408,246 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
Held | 421,236 | $38,913,781 | 11.92% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Added | 500,522 | $37,584,196 | 11.51% | |
| CI |
Cigna Group
Healthcare
|
Added | 137,522 | $36,683,993 | 11.24% | |
| MDT |
Medtronic plc
Healthcare
|
Reduced | 398,065 | $34,492,332 | 10.57% | |
| TFX |
Teleflex Inc
Healthcare
|
NEW | 278,792 | $33,346,311 | 10.22% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Added | 547,871 | $30,949,232 | 9.48% | |
| GRDN |
Guardian Pharmacy Services, Inc.
Healthcare
|
NEW | 631,193 | $23,770,728 | 7.28% | |
| AZN |
Astrazeneca PLC
Healthcare
|
NEW | 110,101 | $21,714,119 | 6.65% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
Added | 79,226 | $21,437,763 | 6.57% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Added | 228,829 | $16,992,841 | 5.21% | |
| AVNS |
Avanos Medical, Inc.
Healthcare
|
NEW | 1,184,909 | $16,600,575 | 5.09% | |
| KOD |
Kodiak Sciences Inc.
Healthcare
|
Reduced | 281,332 | $10,724,375 | 3.29% | |
| TENX |
Tenax Therapeutics, Inc.
Healthcare
|
NEW | 200,000 | $3,198,000 | 0.98% |